Back
Celldex Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
CLDX
Celldex Therapeutics, Inc.
Last Price:
$23.25
Seasonality Move:
-2.68%
7 Day Trial
ALL ACCESS PASS
$
7
Celldex Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Celldex Therapeutics, Inc. has on average historically risen by 34% based on the past 39 years of stock performance.
-
Celldex Therapeutics, Inc. has risen higher in 13 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Celldex Therapeutics, Inc. Stock Undervalued?The current Celldex Therapeutics, Inc. [CLDX] share price is $23.54. The Score for CLDX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CLDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Celldex Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Celldex Therapeutics, Inc. has on average historically risen by 34% based on the past 39 years of stock performance.
Celldex Therapeutics, Inc. Stock Rating
Sell
27
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. overpriced?
-
Celldex Therapeutics, Inc. has risen higher in 13 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Celldex Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celldex.com
52-Week Data
52-Week High:
30.50
52-Week Low:
14.40
Prediction Charts
Market Cap:
1.6B
Price in USD:
23.54
Volume:
582.3K
Beta:
1.79
Technical Analysis
SMA50:
25.82
SMA100:
25.96
SMA200:
23.93
52-Wk Change:
2.13%
Stock Predictions
-
Is Celldex Therapeutics, Inc. stock public?Yes, Celldex Therapeutics, Inc. is a publicly traded company.
-
What is the Celldex Therapeutics, Inc. stock quote today?The Celldex Therapeutics, Inc. stock price is 23.54 USD today.
-
How to buy Celldex Therapeutics, Inc. stock online?You can buy Celldex Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-30 | 24.39 | 24.58 | 24.99 | 23.95 |
| Feb-2 | 24.60 | 24.66 | 25.15 | 24.37 |
| Feb-3 | 24.72 | 25.20 | 25.60 | 24.68 |
| Feb-4 | 25.32 | 24.26 | 25.34 | 24.02 |
| Feb-5 | 24.04 | 22.58 | 24.34 | 22.55 |
| Feb-6 | 23.15 | 23.80 | 23.98 | 22.33 |
| Feb-9 | 23.74 | 24.81 | 24.88 | 23.12 |
| Feb-10 | 24.69 | 24.63 | 25.24 | 24.46 |
| Feb-11 | 24.72 | 24.59 | 25.02 | 23.62 |
| Feb-12 | 24.57 | 23.55 | 24.78 | 23.09 |
| Feb-13 | 23.66 | 23.00 | 24.29 | 22.51 |
| Feb-17 | 22.94 | 22.94 | 23.45 | 22.46 |
| Feb-18 | 22.93 | 23.00 | 23.54 | 22.91 |
| Feb-19 | 22.87 | 23.54 | 23.60 | 22.63 |
Celldex Therapeutics, Inc. Earnings
Celldex Therapeutics, Inc. Earnings Report: Per Share Celldex Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Celldex Therapeutics, Inc. Forecast Revenue Growth
Celldex Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.44 per share.
* Celldex Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.